149 related articles for article (PubMed ID: 414875)
1. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
Calisti G; Biscarini L; Miseo A
Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
[No Abstract] [Full Text] [Related]
2. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
[No Abstract] [Full Text] [Related]
3. [Controlled clinical study on the activity and tolerance of Trivastan].
Nicrosini F; Pasotti C
Minerva Med; 1976 May; 67(26):1745-50. PubMed ID: 778674
[No Abstract] [Full Text] [Related]
4. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
Piguet PV; Zoufal Z
Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
[No Abstract] [Full Text] [Related]
5. Use of Redergam (Latergal) in vascular diseases.
Kovács E
Ther Hung; 1986; 34(4):238-42. PubMed ID: 3449979
[No Abstract] [Full Text] [Related]
6. [Letter: Double blind study of hydergine in aged patients].
Paux G; Boismare F; Delaunay P
Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
[No Abstract] [Full Text] [Related]
7. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency].
Muchnik S
Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466
[No Abstract] [Full Text] [Related]
8. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
Kohler H
Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
[No Abstract] [Full Text] [Related]
9. [Treatment of cerebrovascular insufficiency].
Cosentino F; Baldassarri R
Clin Ter; 1979 Mar; 88(6):631-8. PubMed ID: 380878
[No Abstract] [Full Text] [Related]
10. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
Szobor A; Klein M; Bräuer H
MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511
[No Abstract] [Full Text] [Related]
11. [Clinical experiences with the vascular action of dihydroergocristine].
Tomasi AM; Baggioni GF; Pozzar C
Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
[No Abstract] [Full Text] [Related]
12. [Treatment of cerebral wasting diseases with Card-Hydergin].
Liebhart M
Med Welt; 1976 Nov; 76(48):2341-6. PubMed ID: 794620
[No Abstract] [Full Text] [Related]
13. [Clinical evaluation of a new preparation of Ersilan drops in patients with vascular headaches].
Serclová L
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(5):649-55. PubMed ID: 3155391
[No Abstract] [Full Text] [Related]
14. [Treatment of peripheral vascular diseases with dihydroergocristine].
Moracchini PV; Alfano G; Melandri F
Minerva Cardioangiol; 1978 Apr; 26(4):277-90. PubMed ID: 97601
[No Abstract] [Full Text] [Related]
15. Comparison of the efficacy and safety of daily dosages of 6 mg and 20 mg dihydroergocristine in the treatment of chronic cerebro-vascular disease.
Pagliano FM; Galbiati GC
J Int Med Res; 1995; 23(4):219-27. PubMed ID: 7589764
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients].
Mailland F; Zottino G
Fortschr Med; 1986 Mar; 104(11):239-42. PubMed ID: 3084366
[No Abstract] [Full Text] [Related]
17. DH Ergotoxin (Spofa) sublingual tablets in the treatment of cerebrovascular insufficiency in involution: clinical and experimental psychologic study.
Misurec J; Morávek Z; Náhunek K; Cesková E; Sláma B; Svestka J
Act Nerv Super (Praha); 1978 Dec; 20(4):266-7. PubMed ID: 367038
[No Abstract] [Full Text] [Related]
18. Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine (BL 191) in double-blind tests.
Buckert D; Harwart D
Farmaco Prat; 1976 May; 31(5):264-74. PubMed ID: 773679
[No Abstract] [Full Text] [Related]
19. [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine].
Cosmi F; Caresia L; Panebianco G
Clin Ter; 1986 Feb; 116(3):213-20. PubMed ID: 3698528
[No Abstract] [Full Text] [Related]
20. [The use of Ergocomb in symptoms of cerebrovascular insufficiency].
Pöthig D; Sauer I; Hansen H; Weidnitzer M
Z Alternsforsch; 1983; 38(6):443-9. PubMed ID: 6659572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
